5.1343
Mannkind Corp (MNKD) 最新ニュース
Truist Securities Initiates Coverage on MNKD with 'Buy' Rating a - GuruFocus
MannKind stock initiated with Buy rating at Truist on Tyvaso DPI potential - Investing.com
MannKind Corporation (NASDAQ:MNKD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Will MannKind Corporation stock outperform value stocksMarket Activity Recap & Accurate Intraday Trading Signals - newser.com
Is MannKind Corporation (NNFN) stock a contrarian opportunityPortfolio Risk Report & Intraday High Probability Alerts - newser.com
Why MannKind Corporation (NNFN) stock attracts wealthy investorsTrend Reversal & Safe Entry Momentum Tips - newser.com
What momentum indicators show for MannKind Corporation stock2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
How MannKind Corporation stock performs after earningsJuly 2025 PreEarnings & Weekly High Momentum Picks - newser.com
How MannKind Corporation (NNFN) stock trades under stagflationMarket Activity Report & Free Technical Confirmation Trade Alerts - newser.com
Is MannKind Corporation (NNFN) stock attractive post correction2025 Fundamental Recap & Verified Short-Term Plans - newser.com
MannKind at Jefferies London Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Nigeria
Is MannKind Corporation stock cheap compared to fundamentalsShare Buyback & Safe Swing Trade Setups - newser.com
MannKind at Jefferies London Healthcare Conference: Strategic Growth Insights - Investing.com India
Can MannKind Corporation (NNFN) stock sustain double digit ROE2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Is MannKind Corporation (NNFN) stock a safe buy pre earnings2025 Top Decliners & AI Driven Stock Reports - newser.com
Technical signs of recovery in MannKind CorporationTrade Ideas & Stepwise Trade Signal Implementation - newser.com
Mitsubishi UFJ Asset Management Co. Ltd. Buys Shares of 67,889 MannKind Corporation $MNKD - MarketBeat
Will MannKind Corporation stock maintain dividend yieldQuarterly Performance Summary & Daily Market Momentum Tracking - newser.com
Insider Selling: MannKind (NASDAQ:MNKD) EVP Sells $94,448.31 in Stock - MarketBeat
Can swing trading help recover from MannKind Corporation losses - newser.com
Connor Clark & Lunn Investment Management Ltd. Decreases Position in MannKind Corporation $MNKD - MarketBeat
Insider Sell: Sanjay Singh Sells Shares of MannKind Corp (MNKD) - GuruFocus
Will MannKind Corporation continue its uptrend2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Mannkind EVP Singh sells $94k in stock By Investing.com - Investing.com Canada
Mannkind EVP Singh sells $94k in stock - Investing.com
MannKind (NASDAQ:MNKD) Now Covered by Leerink Partners - MarketBeat
MannKind (NASDAQ:MNKD) Price Target Lowered to $8.00 at Wells Fargo & Company - MarketBeat
Visual analytics tools that track MannKind Corporation performanceMarket Movement Recap & Consistent Profit Trade Alerts - newser.com
Can MannKind Corporation (NNFN) stock attract analyst upgradesJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
MannKind (Nasdaq: MNKD) to present at Jefferies; webcast Nov. 19 at 6:30 am ET - Stock Titan
RBC Capital Maintains MannKind (MNKD) Outperform Recommendation - Nasdaq
MannKind (NASDAQ:MNKD) Shares Gap DownHere's What Happened - MarketBeat
RBC Capital Adjusts MNKD Price Target, Maintains Outperform Rati - GuruFocus
Wells Fargo Lowers Price Target for MannKind (MNKD) Amid Overwei - GuruFocus
MannKind stock price target lowered to $7.50 at RBC on NTM trial failure - Investing.com
MannKind stock falls after discontinuing Phase 3 NTM lung disease trial - Investing.com Canada
Danbury biopharma firm halts late-stage drug trial after disappointing results - Hartford Business Journal
MannKind Corp. Hits Day High with Strong 10.58% Intraday Surge - Markets Mojo
MannKind (MNKD) Halts Phase 3 Trial Due to Ineffectiveness - GuruFocus
大文字化:
|
ボリューム (24 時間):